CN110437076B - Synthesis method of high-purity cinacalcet hydrochloride - Google Patents

Synthesis method of high-purity cinacalcet hydrochloride Download PDF

Info

Publication number
CN110437076B
CN110437076B CN201910781383.3A CN201910781383A CN110437076B CN 110437076 B CN110437076 B CN 110437076B CN 201910781383 A CN201910781383 A CN 201910781383A CN 110437076 B CN110437076 B CN 110437076B
Authority
CN
China
Prior art keywords
cinacalcet hydrochloride
reducing agent
purity
solvent
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910781383.3A
Other languages
Chinese (zh)
Other versions
CN110437076A (en
Inventor
黄乐群
施敏峰
王天天
李玉凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Jiayi Medicine Co ltd
Original Assignee
Jiangsu Jiayi Medicine Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Jiayi Medicine Co ltd filed Critical Jiangsu Jiayi Medicine Co ltd
Priority to CN201910781383.3A priority Critical patent/CN110437076B/en
Publication of CN110437076A publication Critical patent/CN110437076A/en
Application granted granted Critical
Publication of CN110437076B publication Critical patent/CN110437076B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/44Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
    • C07C209/50Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C07C209/74Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton by halogenation, hydrohalogenation, dehalogenation, or dehydrohalogenation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a high-purity saltThe synthesis method of the cinacalcet hydrochloride is characterized in that the cinacalcet hydrochloride is obtained by carrying out reduction reaction on amide shown in a formula IV in a reducing agent, a catalyst and a solvent, hydrolyzing and then carrying out hydrochloric acid salt formation, wherein the solubility of the reducing agent in the used solvent at a reaction temperature is not more than 2.0 g per 100 ml, and the synthesis equation is as follows:
Figure DDA0002175807110000011
the invention has the advantages that: the method for synthesizing the high-purity cinacalcet hydrochloride has the advantages that reasonable combination of the reducing agent and the solvent is selected, the solubility of the selected reducing agent in the used solvent is controlled to be not more than 2.0 g per 100 ml, the high-purity cinacalcet hydrochloride is obtained after reaction, and the content of impurities shown in the formulas II and III in the product can be greatly reduced or even cannot be detected.

Description

Synthesis method of high-purity cinacalcet hydrochloride
Technical Field
The invention belongs to the field of drug synthesis, and particularly relates to a synthesis method of high-purity cinacalcet hydrochloride.
Background
Cinacalcet hydrochloride, which has a structural formula shown in formula I, is a calcimimetic and is approved by the FDA in the United states in 2004 to be marketed in the United states, and is marketed in 2016 in China, and is used for treating hypercalcemia caused by secondary hyperparathyroidism and thyroid cancer of patients suffering from kidney disease attack.
Figure BDA0002175807090000011
There are various methods for synthesizing cinacalcet hydrochloride, which will be described below.
1.1 synthetic route one
Reference is made to the following documents: organic Process Research & Development, 2011,15,455-
Figure BDA0002175807090000021
The synthetic route has the advantages of good yield in each step and little solvent. But the main disadvantages are:
1) the raw material 3- (m-trifluoromethylphenyl) bromopropane is not easy to obtain, and is genotoxic impurity, and the content of the product needs to be strictly controlled.
2) The benzaldehyde by-product as a protecting group is difficult to remove in the post-treatment process.
1.2 synthetic route II
Reference is made to the following documents: organic Process Research & Development, 2012,16,1566-
Figure BDA0002175807090000022
The main disadvantage of this route is its yield
1) The reagent in the current format in the industry has a relatively large danger
2) The final step of hydrogenation with palladium-carbon is prone to bring a large palladium content in the final product, and extra recrystallization or palladium removal steps are required to ensure that the content of metal palladium does not exceed the standard.
3) In the first step of the reaction with 1, 3-dichloropropene, there is the possibility that two alkylation reactions may be carried out to produce the dialkylated compound, which is difficult to remove.
1.3 synthetic route III
In the reference CN 103450027 a, the desired cinacalcet free base can be obtained in one step by condensation reaction using naphthylethylamine and 3- (trifluoromethylphenyl) propanol mesylate, and then salified in MTBE solvent.
Figure BDA0002175807090000031
The main drawbacks of this route are:
1)3- (trifluoromethylphenyl) propanol mesylate is not readily available, and the starting material is a genotoxic impurity that needs to be tightly controlled in the product.
2) The alkylation of amine is difficult to control in the primary substitution stage, and a secondary substitution product of naphthylethylamine is easily formed, which brings difficulty to product separation.
1.4 synthetic route IV
Reference documents: tetrahedron Letters, 2008,49,13-15
Figure BDA0002175807090000041
The biggest problem of this route is that a large amount of formula II is generated during the synthesis
Figure BDA0002175807090000042
And formula III
Figure BDA0002175807090000043
The impurities shown, are difficult to remove in the product.
1.5 synthetic route five
Reference documents: EP2327684
Figure BDA0002175807090000044
All raw materials in the route are easy to obtain, but the consumption of sodium triacetoxyborohydride is too large, and the raw material 3- (3-trifluoromethylphenyl) propionaldehyde is expensive and has poor economy.
Therefore, it is desirable to provide a method for obtaining cinacalcet hydrochloride with high purity in an economical manner.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a method for synthesizing high-purity cinacalcet hydrochloride, which is good in economy and can obtain a high-purity product.
Tetrahedron Letters, 2008,49,13-15 provide a method for synthesizing cinacalcet hydrochloride, and the cinacalcet hydrochloride synthesized by the method has high yield and less impurities. However, the synthesis method reported in this document has a significant drawback in that impurities represented by formula II and formula III are generated during the synthesis process, and the content of impurities in the reaction solution after the reaction is high, and the content of impurities cannot be controlled well even if recrystallization is performed by the method reported in the document. For pharmaceutical substances, the impurities contained in the final product need to be strictly controlled, and the impurities are preferably controlled to be less than 0.15%, and more preferably to be less than 0.10%.
We have repeated the synthesis conditions of this document and found that the impurities of formulae II and III are indeed produced in large amounts, the total amount of both impurities being more than 0.15% in the precipitated cinacalcet hydrochloride crystals. By conventional reaction optimization methods, such as shortening the reaction time or lowering the reaction temperature, there is no satisfactory effect on reducing the content of the impurities represented by the formulae II and III in cinacalcet hydrochloride.
Surprisingly, however, the level of impurities of the formulae III and III can be greatly reduced, even undetectable in the product, by choosing a reasonable combination of reducing agent and solvent during the reduction of the amide (formula IV). The key to this is that the reducing agent selected has a solubility in the solvent used of less than 2.0 g per 100 ml, more preferably less than 0.20 g per 100 ml.
In order to solve the technical problems, the technical scheme of the invention is as follows: the synthesis method of the high-purity cinacalcet hydrochloride is characterized in that the cinacalcet hydrochloride is obtained by carrying out reduction reaction on amide shown in a formula IV in a reducing agent, a catalyst and a solvent, hydrolyzing and then salifying with hydrochloric acid, and the innovation points are that: the solubility of the reducing agent in the solvent used is not more than 2.0 g per 100 ml at the reaction temperature, and the synthesis equation is as follows:
Figure BDA0002175807090000061
further, the reducing agent has a solubility in the solvent used of not more than 0.2 g per 100 ml at the reaction temperature.
Further, the reducing agent is one or a mixture of several of sodium borohydride, potassium borohydride, lithium borohydride or lithium aluminum hydride, the catalyst is one or a mixture of several of Lewis acid or protonic acid, and the solvent is one or a mixture of several of tetrahydrofuran, dioxane and dipropyl ether.
Further, the Lewis acid is boron trifluoride diethyl etherate or boron trifluoride tetrahydrofuran, and the protonic acid is hydrochloric acid or sulfuric acid.
Further, the reducing agent is sodium borohydride, the catalyst is boron trifluoride tetrahydrofuran, and the solvent is tetrahydrofuran.
The invention has the advantages that: according to the synthesis method of the high-purity cinacalcet hydrochloride, reasonable combination of the reducing agent and the solvent is selected, and the solubility of the selected reducing agent in the used solvent is controlled to be not more than 2.0 g per 100 ml, so that the content of impurities shown in the formula II and the formula III can be greatly reduced, and even the impurities cannot be detected in the product; the cinacalcet hydrochloride with the purity of more than 99.5 percent can be synthesized by the invention, wherein the content of the impurities shown in the formulas II and III is less than 0.15 percent, and the purity of 99.8 percent is more preferably obtained, wherein the content of the impurities shown in the formulas II and III is less than 0.10 percent.
Drawings
The present invention will be described in further detail with reference to the accompanying drawings and specific embodiments.
Fig. 1 is a chromatogram of cinacalcet hydrochloride synthesized in example 1.
Fig. 2 is a chromatogram of cinacalcet hydrochloride synthesized in example 2.
Detailed Description
The following examples are presented to enable one of ordinary skill in the art to more fully understand the present invention and are not intended to limit the scope of the embodiments described herein.
Example 1: control description (Synthesis according to the method reported by Tetrahedron Letters, 2008,49, 13-15)
A1000 ml reaction vessel was charged with 47.7 g of an amide represented by the formula IV, 143 g of a mixed solvent of tetrahydrofuran and diglyme (1:1), and 12.4 g of sodium borohydride, and mechanically stirred, 68 g of boron trifluoride complex was added dropwise at 40 to 60 ℃ and, after completion of the addition, reacted at 40 to 60 ℃ for 3 hours. Adding 270 g of water for quenching reaction, adding 290 g of toluene for extraction, reserving an organic phase, washing by using 270 g of water, adding 17.3 g of concentrated hydrochloric acid for salt formation, crystallizing by using 190 g of n-heptane at 70 ℃, cooling to normal temperature, filtering, and drying to obtain 42 g of cinacalcet hydrochloride crystals with the purity of 99.4 percent, wherein the sum of the impurities shown in the formula II and the formula III is 0.284 percent.
The detection method comprises the following steps: a chromatographic column: octylsilane bonded silica gel (Inertsil C8, 4.6 mm. times.150 mm, 5 μm or equivalent performance column). Mobile phase: phase A: sodium dodecyl sulfate solution (sodium dodecyl sulfate 5.05g, dissolved by adding water 900ml, added with phosphoric acid 0.35ml, diluted to 1000ml with water), phase B: acetonitrile; elution was performed according to the following gradient 1:
TABLE 1
Figure BDA0002175807090000071
Figure BDA0002175807090000081
Detection wavelength: 210 nm.
Flow rate: 1.2ml/min
Column temperature: at 50 ℃.
Sample introduction amount: 10 μ l.
The impurities represented by formula II and formula III cannot be separated from each other, and the degree of separation of the main peak from it is not less than 1.5, calculated as the total amount. The detection spectrum is shown in figure 1, and the test data of each peak number on figure 1 are shown in the following table 2.
TABLE 2 detection peak table of cinacalcet hydrochloride
Detector A210 nm
Figure BDA0002175807090000082
From FIG. 1 and Table 2, it can be seen that the total amount of impurities represented by the formulae II and III is 0.284%.
Example 2
In a 1000ml reaction flask, 47.7 g of amide shown in formula IV, 143 g of tetrahydrofuran and 12.4 g of sodium borohydride are added, mechanically stirred, 68 g of boron trifluoride complex is dropwise added at 40-60 ℃, and after dropwise addition, the mixture is reacted for 3 hours at 40-60 ℃. Adding 270 g of water for quenching reaction, adding 290 g of toluene for extraction, reserving an organic phase, washing by using 270 g of water, adding 17.3 g of concentrated hydrochloric acid for salt formation, crystallizing by using 190 g of n-heptane at 70 ℃, cooling to normal temperature, filtering, and drying to obtain 45 g of cinacalcet hydrochloride crystals with the purity of 99.8 percent, wherein the impurities shown in the formula II and the formula III are not detected (the content corresponding to the detection limit is less than 0.01 percent).
The detection method comprises the following steps: a chromatographic column: octylsilane bonded silica gel (Inertsil C8, 4.6 mm. times.150 mm, 5 μm or equivalent performance column). Mobile phase: phase A: sodium dodecyl sulfate solution (sodium dodecyl sulfate 5.05g, dissolved by adding water 900ml, added with phosphoric acid 0.35ml, diluted to 1000ml with water), phase B: acetonitrile; elution was performed according to the following gradient 3:
TABLE 3
Figure BDA0002175807090000091
Detection wavelength: 210 nm.
Flow rate: 1.2ml/min
Column temperature: at 50 ℃.
Sample introduction amount: 10 μ l.
The impurities represented by formula II and formula III cannot be separated from each other, and the degree of separation of the main peak from it is not less than 1.5, calculated as the total amount. The detection spectrum is shown in figure 2, and the test data of each peak number on figure 2 are shown in the following table 4.
TABLE 4 detection peak table of cinacalcet hydrochloride
Detector A210 nm
Figure BDA0002175807090000101
From FIG. 2 and Table 4, it can be seen that the total amount of impurities represented by the formulae II and III was not detected.
The foregoing shows and describes the general principles and features of the present invention, together with the advantages thereof. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are described in the specification and illustrated only to illustrate the principle of the present invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the present invention, which fall within the scope of the invention as claimed. The scope of the invention is defined by the appended claims and equivalents thereof.

Claims (2)

1. A method for synthesizing high-purity cinacalcet hydrochloride, which is obtained by carrying out reduction reaction on amide shown in a formula IV in a reducing agent, a catalyst and a solvent, hydrolyzing and then salifying hydrochloric acid, and is characterized in that: the solubility of the reducing agent in the solvent used is not more than 2.0 g per 100 ml at the reaction temperature, and the synthesis equation is as follows:
Figure DEST_PATH_IMAGE001
the reducing agent is sodium borohydride, the catalyst is boron trifluoride tetrahydrofuran, and the solvent is tetrahydrofuran.
2. The method of synthesizing high purity cinacalcet hydrochloride according to claim 1, characterized in that: the reducing agent has a solubility in the solvent used of not more than 0.2 g per 100 ml at the reaction temperature.
CN201910781383.3A 2019-08-22 2019-08-22 Synthesis method of high-purity cinacalcet hydrochloride Active CN110437076B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910781383.3A CN110437076B (en) 2019-08-22 2019-08-22 Synthesis method of high-purity cinacalcet hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910781383.3A CN110437076B (en) 2019-08-22 2019-08-22 Synthesis method of high-purity cinacalcet hydrochloride

Publications (2)

Publication Number Publication Date
CN110437076A CN110437076A (en) 2019-11-12
CN110437076B true CN110437076B (en) 2021-03-30

Family

ID=68437148

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910781383.3A Active CN110437076B (en) 2019-08-22 2019-08-22 Synthesis method of high-purity cinacalcet hydrochloride

Country Status (1)

Country Link
CN (1) CN110437076B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112374999A (en) * 2020-11-26 2021-02-19 福安药业集团重庆礼邦药物开发有限公司 Preparation method of impurity compound for defluorination of cinacalcet hydrochloride

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103739500B (en) * 2012-12-27 2016-03-23 国药一心制药有限公司 A kind of synthesis of cinacalcet hydrochloride and process for purification
CN103467304A (en) * 2013-08-07 2013-12-25 南京生命能科技开发有限公司 Cinacalcet hydrochloride preparation method

Also Published As

Publication number Publication date
CN110437076A (en) 2019-11-12

Similar Documents

Publication Publication Date Title
EP1704138A1 (en) Processes for the preparation of tomoxetine
CN110437076B (en) Synthesis method of high-purity cinacalcet hydrochloride
EP3201171B1 (en) Method of preparing intermediate of salmeterol
US20060211772A1 (en) Processes for the preparation of atomoxetine hydrochloride
CN106831441B (en) A kind of preparation method of cinacalcet hydrochloride
US9469593B2 (en) Process for preparing cinacalcet hydrochloride
CN107353221A (en) A kind of Preparation method and use of chipal compounds
CN105646261A (en) Tetracaine preparation method
AU2021404731B2 (en) Synthesis method for cyclopropyl-containing chiral amine hydrochloride
CN103467304A (en) Cinacalcet hydrochloride preparation method
CN107963965B (en) Preparation method of m-trifluoromethyl phenylpropionic acid
US20140378699A1 (en) Process for the preparation of fesoterodine
CN110655466B (en) Preparation method of benzphetamine hydrochloride
CN109535006B (en) Intermediate and method for preparing cinacalcet hydrochloride
CN111704577A (en) Preparation method of cinacalcet hydrochloride
CN111517962A (en) Preparation method of amine anti-aging agent
CN117050035B (en) Preparation method of hydrobromic acid voltammetric acid duloxetine
CN106543010A (en) A kind of method of synthetic hydrochloric acid cinacalcet
CN115286504B (en) Method for synthesizing (R) -2- (2- (tert-butoxy) -2-oxyethyl) pentanoic acid
EP3619186A1 (en) Process for the production of semifluorinated alkanes
CN101781160B (en) Method for synthesizing tetracyclo[7.3.1.02,7.17,11]tetradecane
CN110845369B (en) Synthetic method of dapoxetine and intermediate thereof
CN106543008A (en) A kind of method of synthesis Sensipar cinacalcet hydrochloride
JP3159522B2 (en) Method for producing high-purity m-phenylenediamine
CN117024288A (en) Synthesis method of tomoxetine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Huang Lequn

Inventor after: Shi Minfeng

Inventor after: Wang Lei

Inventor after: Wang Tiantian

Inventor after: Li Yufeng

Inventor before: Huang Lequn

Inventor before: Shi Minfeng

Inventor before: Wang Tiantian

Inventor before: Li Yufeng

CB03 Change of inventor or designer information